Enhertu 100 mg

Enhertu 100 mg is a medicine authorised by Swissmedic under authorisation number 67967. The authorisation holder is Daiichi Sankyo (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 November 2021 and the authorisation is valid without a time limit. ATC code L01FD04 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 67967
  • ATC L01FD04
  • Biotechnological medicines
Authorisation data
Authorisation number67967
NameEnhertu 100 mg
Full nameEnhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderDaiichi Sankyo (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FD04
First authorisation29 November 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Enhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA29 November 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FD0407.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Enhertu 100 mg authorised in Switzerland?

Yes. Enhertu 100 mg is authorised by Swissmedic under authorisation number 67967, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Enhertu 100 mg have?

Enhertu 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Enhertu 100 mg?

The authorisation holder is Daiichi Sankyo (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com